Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-01-14 Purchase | 2025-01-15 07:00 am | Cogent Biosciences Inc. | COGT | Pinnow Cole Chief Commercial Officer | 43,750 | $7.598 | $332,413 | 45,848 (Direct) | View |
| 2023-06-09 Purchase | 2023-06-13 4:07 pm | Cogent Biosciences Inc. | COGT | Fairmount Funds Management LLC See Remarks 10% Owner | 800,000 | $12 | $9,600,000 | 3,626,389 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-01-23 Option Award | 2025-01-27 5:03 pm | N/A 2035-01-23 | Cogent Biosciences Inc. | COGT | Green John L. Chief Financial Officer | 270,000 | $0 | 270,000 (Direct) | View |
| 2025-01-23 Option Award | 2025-01-27 5:00 pm | N/A 2035-01-23 | Cogent Biosciences Inc. | COGT | Pinnow Cole Chief Commercial Officer | 240,000 | $0 | 240,000 (Direct) | View |
| 2025-01-23 Option Award | 2025-01-27 4:58 pm | N/A 2035-01-23 | Cogent Biosciences Inc. | COGT | Robinson John Edward Chief Scientific Officer | 270,000 | $0 | 270,000 (Direct) | View |
| 2025-01-23 Option Award | 2025-01-27 4:56 pm | N/A 2035-01-23 | Cogent Biosciences Inc. | COGT | Sachs Jessica Chief Medical Officer | 270,000 | $0 | 270,000 (Direct) | View |
| 2025-01-23 Option Award | 2025-01-27 4:56 pm | N/A 2035-01-23 | Cogent Biosciences Inc. | COGT | Robbins Andrew R President and CEO | 915,000 | $0 | 915,000 (Direct) | View |
| 2025-01-23 Option Award | 2025-01-27 4:55 pm | N/A 2035-01-23 | Cogent Biosciences Inc. | COGT | Kearns Evan Chief Legal Officer | 230,000 | $0 | 230,000 (Direct) | View |
| 2025-01-01 Option Award | 2025-01-03 4:21 pm | 2025-01-01 2035-01-01 | Cogent Biosciences Inc. | COGT | Ferrante Karen Jean Director | 2,785 | $0 | 2,785 (Direct) | View |
| 2024-10-01 Option Award | 2024-10-02 4:14 pm | 2024-10-01 2034-10-01 | Cogent Biosciences Inc. | COGT | Ferrante Karen Jean Director | 2,034 | $0 | 2,034 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-02 4:31 pm | 2024-07-01 2034-07-01 | Cogent Biosciences Inc. | COGT | Ferrante Karen Jean Director | 2,462 | $0 | 2,462 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-13 7:18 pm | N/A 2034-06-05 | Cogent Biosciences Inc. | COGT | CAIN CHRISTOPHER W. Director | 44,700 | $0 | 44,700 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-13 7:14 pm | N/A 2034-06-05 | Cogent Biosciences Inc. | COGT | Ros Matthew Director | 44,700 | $0 | 44,700 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-13 7:14 pm | N/A 2034-06-05 | Cogent Biosciences Inc. | COGT | Ferrante Karen Jean Director | 44,700 | $0 | 44,700 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-13 7:11 pm | N/A 2034-06-05 | Cogent Biosciences Inc. | COGT | Harwin Peter Evan Director | 44,700 | $0 | 44,700 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-13 7:07 pm | N/A 2034-06-05 | Cogent Biosciences Inc. | COGT | Shegog Todd Director | 44,700 | $0 | 44,700 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-13 7:06 pm | N/A 2034-06-05 | Cogent Biosciences Inc. | COGT | Morris Arlene Director | 44,700 | $0 | 44,700 (Direct) | View |
| 2024-06-10 Exercise | 2024-06-12 9:01 pm | N/A N/A | Cogent Biosciences Inc. | COGT | Fairmount Funds Management LLC Director | 1,501,500 | $0 | 6,225,641 (Indirect) | View |
| 2024-05-25 Option Award | 2024-05-29 4:03 pm | N/A 2034-05-25 | Cogent Biosciences Inc. | COGT | Pinnow Cole Chief Commercial Officer | 525,000 | $0 | 525,000 (Direct) | View |
Ownership | 2024-05-29 4:01 pm | N/A N/A | Cogent Biosciences Inc. | COGT | Pinnow Cole Chief Commercial Officer | 0 | $0 | 700 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-02 6:21 pm | 2024-04-01 2034-04-01 | Cogent Biosciences Inc. | COGT | Ferrante Karen Jean Director | 3,213 | $0 | 3,213 (Direct) | View |
| 2024-03-28 Other | 2024-04-01 6:19 pm | N/A N/A | Cogent Biosciences Inc. | COGT | Fairmount Funds Management LLC Director | 310,679 | $0 | 5,366,757 (Indirect) | View |
| 2024-02-16 Option Award | 2024-02-16 6:43 pm | N/A N/A | Cogent Biosciences Inc. | COGT | Fairmount Funds Management LLC 10% Owner | 1,166,666 | $7.5 | 4,727,141 (Indirect) | View |
| 2024-02-16 Option Award | 2024-02-16 6:43 pm | N/A N/A | Cogent Biosciences Inc. | COGT | Fairmount Funds Management LLC 10% Owner | 1,500 | $7,500 | 4,727,141 (Indirect) | View |
| 2024-01-23 Option Award | 2024-01-25 4:36 pm | N/A 2034-01-23 | Cogent Biosciences Inc. | COGT | Robinson John Edward Chief Scientific Officer | 300,000 | $0 | 300,000 (Direct) | View |
| 2024-01-23 Option Award | 2024-01-25 4:27 pm | N/A 2034-01-23 | Cogent Biosciences Inc. | COGT | Kearns Evan Chief Legal Officer | 255,000 | $0 | 255,000 (Direct) | View |
| 2024-01-23 Option Award | 2024-01-25 4:20 pm | N/A 2034-01-23 | Cogent Biosciences Inc. | COGT | Sachs Jessica Chief Medical Officer | 300,000 | $0 | 300,000 (Direct) | View |
| 2024-01-23 Option Award | 2024-01-25 4:20 pm | N/A 2034-01-23 | Cogent Biosciences Inc. | COGT | Robbins Andrew R President and CEO | 1,100,000 | $0 | 1,100,000 (Direct) | View |
| 2024-01-23 Option Award | 2024-01-25 4:17 pm | N/A 2034-01-23 | Cogent Biosciences Inc. | COGT | Green John L. Chief Financial Officer | 300,000 | $0 | 300,000 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:24 pm | 2024-01-02 2034-01-02 | Cogent Biosciences Inc. | COGT | Ferrante Karen Jean Director | 3,298 | $0 | 3,298 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:20 pm | 2024-01-02 2034-01-02 | Cogent Biosciences Inc. | COGT | Ros Matthew Director | 3,051 | $0 | 3,051 (Direct) | View |
| 2023-10-02 Option Award | 2023-10-03 4:56 pm | 2023-10-02 2033-10-02 | Cogent Biosciences Inc. | COGT | Ros Matthew Director | 2,170 | $0 | 2,170 (Direct) | View |
| 2023-10-02 Option Award | 2023-10-03 4:51 pm | 2023-10-02 2033-10-02 | Cogent Biosciences Inc. | COGT | Ferrante Karen Jean Director | 2,345 | $0 | 2,345 (Direct) | View |
| 2023-07-03 Option Award | 2023-07-05 4:53 pm | 2023-07-03 2033-07-03 | Cogent Biosciences Inc. | COGT | Ferrante Karen Jean Director | 1,884 | $0 | 1,884 (Direct) | View |
| 2023-07-03 Option Award | 2023-07-05 4:53 pm | 2023-07-03 2033-07-03 | Cogent Biosciences Inc. | COGT | Ros Matthew Director | 1,743 | $0 | 1,743 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-08 4:58 pm | N/A 2033-06-07 | Cogent Biosciences Inc. | COGT | Morris Arlene Director | 36,700 | $0 | 36,700 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-08 4:52 pm | N/A 2033-06-07 | Cogent Biosciences Inc. | COGT | CAIN CHRISTOPHER W. Director | 36,700 | $0 | 36,700 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-08 4:47 pm | N/A 2033-06-07 | Cogent Biosciences Inc. | COGT | Ferrante Karen Jean Director | 36,700 | $0 | 36,700 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-08 4:43 pm | N/A 2033-06-07 | Cogent Biosciences Inc. | COGT | Shegog Todd Director | 36,700 | $0 | 36,700 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-08 4:41 pm | N/A 2033-06-07 | Cogent Biosciences Inc. | COGT | Ros Matthew Director | 36,700 | $0 | 36,700 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-08 4:37 pm | N/A 2033-06-07 | Cogent Biosciences Inc. | COGT | Harwin Peter Evan Director | 36,700 | $0 | 36,700 (Direct) | View |